Hcw Biologics logo

Hcw Biologics Share Price (NASDAQ: HCWB)

$5.73

0.05

(0.88%)

Last updated on

Check the interactive Hcw Biologics Stock chart to analyse performance

Hcw Biologics stock performance

as on August 30, 2025 at 1:27 am IST

  • Today's Low:$5.62
    Today's High:$5.95

    Day's Volatility :5.55%

  • 52 Weeks Low:$2.77
    52 Weeks High:$100.80

    52 Weeks Volatility :97.25%

Hcw Biologics Stock Returns

PeriodHcw Biologics IncIndex (Russel 2000)
3 Months
-19.28%
0.0%
6 Months
-61.71%
0.0%
1 Year
-65.36%
0.0%
3 Years
-94.29%
-4.7%

Hcw Biologics Inc Key Stats

Check Hcw Biologics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.68
Open
$5.79
Today's High
$5.95
Today's Low
$5.62
Market Capitalization
$13.0M
Today's Volume
$180.8K
52 Week High
$100.8
52 Week Low
$2.77
Revenue TTM
$832.8K
EBITDA
$-12.0M
Earnings Per Share (EPS)
$-16.41
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-27725.96%

Stock Returns calculator for Hcw Biologics Stock including INR - Dollar returns

The Hcw Biologics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Hcw Biologics investment value today

Current value as on today

₹39,391

Returns

₹60,609

(-60.61%)

Returns from Hcw Biologics Stock

₹65,893 (-65.89%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Hcw Biologics Stock

500.0%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Hcw Biologics Shares from India has grown by 500.0% over the past 30 days, indicating increased transactional activity.

571%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Hcw Biologics Stock from India on INDmoney has increased by 571% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Hcw Biologics Inc

  • Name

    Holdings %

  • Geode Capital Management, LLC

    0.28%

  • J.W. COLE ADVISORS, INC.

    0.06%

  • BlackRock Inc

    0.05%

  • AE Wealth Management LLC

    0.03%

  • State Street Corp

    0.03%

  • JustInvest LLC

    0.02%

Analyst Recommendation on Hcw Biologics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Hcw Biologics(by analysts ranked 0 to 5 stars)

Hcw Biologics Share Price Target

What analysts predicted

Upside of 510.82%

Target:

$35.00

Current:

$5.73

Hcw Biologics share price target is $35.00, a slight Upside of 510.82% compared to current price of $5.73 as per analysts' prediction.

Hcw Biologics Stock Insights

  • Price Movement

    In the last 7 days, HCWB stock has moved up by 68.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 5.06K → 6.55K (in $), with an average increase of 22.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -2.19M → -12.08M (in $), with an average decrease of 449.9% per quarter
  • HCWB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 138.3%
  • HCWB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 206.9%
  • Price to Sales

    ForHCWB every $1 of sales, investors are willing to pay $8.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Hcw Biologics Technicals Summary

Sell

Neutral

Buy

Hcw Biologics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Hcw Biologics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Hcw Biologics Inc logo
37.26%
-61.71%
-65.36%
-94.29%
-97.69%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Hcw Biologics Inc

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Organization
Hcw Biologics
Employees
36
CEO
Dr. Hing C. Wong Ph.D.
Industry
Miscellaneous

Key Management of Hcw Biologics Inc

NameTitle
Dr. Hing C. Wong Ph.D.
Founder, CEO, Director & Secretary
Dr. Peter Rhode Ph.D.
Chief Scientific Officer & VP of Clinical Operations
Ms. Nicole Valdivieso Esq.
Vice President of Legal Affairs
Mr. Lee D. Flowers
Senior Vice President of Business Development

Important FAQs about investing in HCWB Stock from India :

What is Hcw Biologics share price today?

Hcw Biologics share price today is $5.73 as on at the close of the market. Hcw Biologics share today touched a day high of $5.95 and a low of $5.62.

What is the 52 week high and 52 week low for Hcw Biologics share?

Hcw Biologics share touched a 52 week high of $100.80 and a 52 week low of $2.77. Hcw Biologics stock price today i.e. is closed at $5.73, lower by 94.32% versus the 52 week high.

How to invest in Hcw Biologics Stock (HCWB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Hcw Biologics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hcw Biologics Shares that will get you 0.2618 shares as per Hcw Biologics share price of $5.73 per share as on August 30, 2025 at 1:27 am IST.

What is the minimum amount required to buy Hcw Biologics Stock (HCWB) from India?

Indian investors can start investing in Hcw Biologics (HCWB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Hcw Biologics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Hcw Biologics share’s latest price of $5.73 as on August 30, 2025 at 1:27 am IST, you will get 1.7452 shares of Hcw Biologics. Learn more about fractional shares .

What are the returns that Hcw Biologics has given to Indian investors in the last 5 years?

Hcw Biologics stock has given -97.69% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?